Early Onset of Clinical Improvement with Ixekizumab in a Randomized, Open-label Study of Patients with Moderate-to-severe Plaque Psoriasis May 1, 2018 by Saakshi Khattri, MD; Orin Goldblum, MD; Kathleen Solotkin, MSN; Yasmin Amir, CONTINUE READING »
Coal Tar 2% Foam in Combination with a Superpotent Corticosteroid Foam for Plaque Psoriasis Case Report and Clinical Implications October 18, 2010 Amylynne J. Frankel, MD, Mount Sinai Medical Center, New York, New York; CONTINUE READING »
Use of Topical Coal Tar Foam for the Treatment of Psoriasis in Difficult-to-treat Areas September 14, 2010 Joshua A. Zeichner, MD Mount Sinai Medical Center, New York, New York CONTINUE READING »